Bio€quity Europe 2026 to take place in Prague – first edition in Central and Eastern Europe
Prague.bio cluster announced today that Bio€quity Europe will make its debut in Central and Eastern Europe in 2026, with the Czech capital selected to host the event. Scheduled for 4 to 6 May, the conference reflects Prague’s rising profile as a strategic gateway for investors seeking access to the region’s fast-growing life sciences ecosystem.
Czechia wants to be on the global biotechnology map
The Czech Republic has significant scientific potential, and biotechnology is one of the most promising fields which importance will only grow in the future. We also have many successfully applied research results. However, the biotechnology sector needs greater visibility, both within the country and especially abroad. That is why new initiatives and clusters are emerging to strengthen international cooperation. One such initiative is Prague.bio, founded in 2023. Our goal is to establish Prague as a biotechnology hub in the heart of Europe, representing and connecting key players from companies, startups, research institutions, investors, and government bodies. After more than a year of operation, Prague.bio now has 21 members, including global pharmaceutical companies, promising startups, research institutions, and universities.
Prague.bio members participate in business mission with Czech president in Switzerland
Key representatives from Prague.bio, IOCB Tech and other leading members of the Czech biotech community, participated in a high-profile business mission in Switzerland, which accompanied the President of the Czech Republic, Petr Pavel, on his state visit. Organized by the Czech Chamber of Commerce, this mission aimed to deepen commercial and research partnerships between the Czech Republic and Switzerland, particularly in the fields of biotechnology, pharmaceuticals, and innovation.
IOCB Tech family and Prague.bio spotlight Czech biotech innovation at Bio-Europe in Stockholm
Celebrating 30 years of fostering global partnerships in the life sciences, this year’s BIO-Europe conference has taken on a distinctly Swedish flavour with a special nod to ABBA. The iconic biotech gathering, nowadays held in Stockholm is not only a celebration of three decades of collaboration but also a showcase of innovation at the heart of the industry. The IOCB Tech Family, Prague.bio and other companies are proud to represent the Czech biotech sector at this landmark event, where ABBA-themed sessions are sparking creative discussions and new partnerships.
Biotechnology organization Prague.bio celebrates its 1-year anniversary
The second edition of Prague.bio Conference, held on this occasion, brought together global experts on technology transfer and the creation of biotech startups, awarded the best startup presentations and introduced the upcoming educational academy for future spin-off managers.
Bristol Myers Squibb to support the development of biotechnology in the Czech Republic
One of the world’s largest biopharmaceutical companies, Bristol Myers Squibb, is joining Prague.bio, an association focused on advancing the biotechnology sector in the Czech Republic. Through its membership, Bristol Myers Squibb aims to support the promising ideas from Czech scientific institutions. Globally, the company focuses on cardiology, neurology, gene therapy, and innovations in cancer research, particularly immunotherapy.
Prague.bio joins EuropaBio: integrating biotech in the Czech Republic
EuropaBio is pleased to announce that Prague.bio has joined as a representative of biotechnology innovation within the Czech Republic.
The first edition of the IP Clinic was conducted in collaboration with Dentons
Prague.bio is always seeking ways to foster the expertise and skills of its members. Thanks to ongoing cooperation with Dentons Patent Solutions, we organised the first edition of IP Clinic on Monday, April 15 – a workshop on IP strategies focusing on TTOs and biotech start-ups.
Prague.bio has expanded its ranks with a significant industry representative – Zentiva joins the association
Prague.bio is a professional association aimed at developing the biotechnology sector in the Czech Republic and assisting in its visibility on the international stage. So far, it has brought together institutions representing highly professional research centers with a strong influence on the development of new drugs, diagnostic methods, and other medical technologies. Now, the first industry representative, Zentiva, has joined the Prague.bio biotechnology cluster.
Petra Kinzlova became the new director of the Prague.bio cluster
Prague, February 1, 2024 – Since February 2024, Petra Kinzlova has succeeded Jiri Fusek as the new CEO of Prague.bio. Jiri has moved to the position of Managing Director and will be responsible for organizing the Prague.bio Conference.